BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32752126)

  • 1. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.
    Matiadis D; Sagnou M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
    Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS
    Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroidal pyrazolines as a promising scaffold in drug discovery.
    Bansal R; Singh R
    Future Med Chem; 2020 May; 12(10):949-959. PubMed ID: 32319322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
    Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
    Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
    Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
    Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
    Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activities of pyrazoline derivatives--a recent development.
    Kumar S; Bawa S; Drabu S; Kumar R; Gupta H
    Recent Pat Antiinfect Drug Discov; 2009 Nov; 4(3):154-63. PubMed ID: 19545230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A; Singla R; Jaitak V
    Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors.
    George RF; Samir EM; Abdelhamed MN; Abdel-Aziz HA; Abbas SE
    Bioorg Chem; 2019 Mar; 83():186-197. PubMed ID: 30380447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Molecules Containing a 7-Chloro-4-aminoquinoline Nucleus and a Substituted 2-Pyrazoline with Antiproliferative and Antifungal Activity.
    Montoya A; Quiroga J; Abonia R; Derita M; Sortino M; Ornelas A; Zacchino S; Insuasty B
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27472314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of 1,2,3-triazole tethered Pyrazoline and Chalcone Derivatives.
    Hussaini SM; Yedla P; Babu KS; Shaik TB; Chityal GK; Kamal A
    Chem Biol Drug Des; 2016 Jul; 88(1):97-109. PubMed ID: 26854643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties.
    Zhao JW; Wu ZH; Guo JW; Huang MJ; You YZ; Liu HM; Huang LH
    Eur J Med Chem; 2019 Nov; 181():111520. PubMed ID: 31404863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.
    Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid.
    Dhawan S; Awolade P; Kisten P; Cele N; Pillay AS; Saha S; Kaur M; Jonnalagadda SB; Singh P
    Chem Biodivers; 2020 Jan; 17(1):e1900462. PubMed ID: 31788939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-triazole conjugates: A brief overview of synthesis and their application as anticancer agents.
    Agarwal DS; Sakhuja R; Beteck RM; Legoabe LJ
    Steroids; 2023 Sep; 197():109258. PubMed ID: 37330161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Pyrazolines as Biologically Active and Fluorescent Agents, An Overview.
    Singh P; Singh J; Pant GJ; Rawat MSM
    Anticancer Agents Med Chem; 2018; 18(10):1366-1385. PubMed ID: 29532762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
    Liu CF; Shen QK; Li JJ; Tian YS; Quan Z
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.